The aims of our current study is to investigate the involvement of serum HMGB-1, OPG, HsCRP, TNF-alpha, IL-6 levels on the presence and severity of PAD in patients with T2D. This evidence concerns the gene TNFRSF11B and type 2 diabetes mellitus.